These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26248120)

  • 1. Direct-acting antiviral-based therapy for acute hepatitis C coinfection.
    Boesecke C; Page E
    Curr Opin HIV AIDS; 2015 Sep; 10(5):330-6. PubMed ID: 26248120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How will we manage acute HCV in men having sex with men in the era of all oral therapy?
    Boesecke C; Rockstroh JK
    J Viral Hepat; 2015 Jan; 22(1):2-7. PubMed ID: 25333810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hepatitis C in patients with HIV.
    Boesecke C; Rockstroh JK
    Semin Liver Dis; 2012 May; 32(2):130-7. PubMed ID: 22760652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
    Walsh N; Maher L
    Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
    Nevot M; Boesecke C; Parera M; Andrés C; Franco S; Revollo B; Ingiliz P; Tural C; Clotet B; Rockstroh JK; Martinez MA;
    J Viral Hepat; 2014 Jun; 21(6):e19-28. PubMed ID: 24674023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms.
    Cooper CL; Klein MB
    HIV Med; 2014 Nov; 15(10):621-4. PubMed ID: 24802099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simeprevir for the treatment of hepatitis C and HIV/hepatitis C co-infection.
    Flanagan S; Crawford-Jones A; Orkin C
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):691-704. PubMed ID: 25209158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?
    Gómez-Ayerbe C; Palacios R; Ríos MJ; Téllez F; Sayago C; Martín-Aspas A; Camacho A; Muñoz L; Santos J;
    Int J STD AIDS; 2021 Nov; 32(13):1257-1260. PubMed ID: 34293985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions.
    Chan J; Chung RT
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):147-163. PubMed ID: 28263458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hepatitis C infection in HIV-positive patients.
    Vogel M; Boesecke C; Rockstroh JK
    Curr Opin Infect Dis; 2011 Feb; 24(1):1-6. PubMed ID: 21178562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights.
    Martin NK; Thornton A; Hickman M; Sabin C; Nelson M; Cooke GS; Martin TCS; Delpech V; Ruf M; Price H; Azad Y; Thomson EC; Vickerman P
    Clin Infect Dis; 2016 May; 62(9):1072-1080. PubMed ID: 26908813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.
    Martinello M; Hajarizadeh B; Grebely J; Dore GJ; Matthews GV
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):110-121. PubMed ID: 28432579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions of hepatitis C direct-acting antivirals in the HIV-infected person.
    El-Sherif O; Back D
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):336-43. PubMed ID: 26159742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
    Rockstroh JK
    Liver Int; 2015 Jan; 35 Suppl 1():51-5. PubMed ID: 25529087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute hepatitis C infection in HIV-infected patients.
    Boesecke C; Rockstroh JK
    Curr Opin HIV AIDS; 2011 Jul; 6(4):278-84. PubMed ID: 21519248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient.
    Rodríguez-Torres M
    Curr Opin Infect Dis; 2013 Feb; 26(1):50-7. PubMed ID: 23242341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing HIV/hepatitis C co-infection in the era of direct acting antivirals.
    Rockstroh JK; Bhagani S
    BMC Med; 2013 Nov; 11():234. PubMed ID: 24228933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection.
    Jafari A; Khalili H; Izadpanah M; Dashti-Khavidaki S
    Expert Opin Drug Saf; 2015 May; 14(5):713-31. PubMed ID: 25813487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions to reduce acute hepatitis C virus in HIV-positive MSM.
    Elliott T; Cooke GS; Garvey L
    Curr Opin Infect Dis; 2020 Feb; 33(1):1-9. PubMed ID: 31789696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future of hepatitis C therapy: development of direct-acting antivirals.
    Dore GJ; Matthews GV; Rockstroh J
    Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.